Background: Liver injury potentially induced by interactions between simvastatin and
Gardeniae Fructus in patients with symptoms of non-alcoholic steatohepatitis (NASH) was …

Background and Purpose Altered drug pharmacokinetics is a significant concern in non‐
alcoholic steatohepatitis (NASH) patients. Although high‐fat high‐cholesterol (HFHC) diet …

Concurrent use of simvastatin (SV) and Gardenia jasminoides J. Ellis (GJ) was adopted in
patients with multi-morbidity, such as stroke rehabilitation patients with NASH. Although …

Context Patients with non-alcoholic steatohepatitis (NASH) may have a simultaneous intake
of pravastatin and evodiamine-containing herbs. Objective The effect of evodiamine on the …

Abstract Ethnopharmacological relevance Fructus Schisandrae is traditionally used as a
liver-toning Chinese herb. Recent studies suggested Fructus Schisandrae could prevent …

Abstract Background/Aims Statins, which are inhibitors of 3‐hydroxy‐3‐methylglutaryl
coenzyme A reductase and inhibit endogenous cholesterol synthesis, possess pleiotropic …

Nonalcoholic fatty liver disease (NAFLD) progresses from simple fatty liver (SFL) to
nonalcoholic steatohepatitis (NASH). This progression alters hepatic organic anion …

Objective. Berberine has been used to treat nonalcoholic steatohepatitis (NASH), which has
been addressed in many studies. In this study, we investigated the molecular pharmacology …

ABSTRACT Background The prevalence of Non-alcoholic fatty liver disease (NAFLD)
including non-alcoholic steatohepatitis (NASH) has increased by 15–39% worldwide, but no …

Rats that consumed a high-fat and high-sucrose diet (HF diet) developed hepatic steatosis.
Treatment of HF diet-fed rats with fluvastatin (8 mg/kg) was lethal, followed by an elevation in …